Intratumoral Targeted Hyperthermia Therapy (THT) for Stage 3C/3D/4M1 Cutaneous Metastatic Melanoma
Clinical trial NCT06894407 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06894407
- Sponsor
- Sona Nanotech Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.